Details for New Drug Application (NDA): 012427
✉ Email this page to a colleague
NDA 012427 describes DIDREX, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the DIDREX profile page.
The generic ingredient in DIDREX is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
The generic ingredient in DIDREX is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
Summary for 012427
| Tradename: | DIDREX |
| Applicant: | Pfizer |
| Ingredient: | benzphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012427
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
